Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression

Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroscience research 1999-11, Vol.58 (4), p.593-598
Hauptverfasser: Serou, Michael J., DeCoster, Mark A., Bazan, Nicolas G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 598
container_issue 4
container_start_page 593
container_title Journal of neuroscience research
container_volume 58
creator Serou, Michael J.
DeCoster, Mark A.
Bazan, Nicolas G.
description Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) genes by IL‐1β in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL‐1β (1 nM) led to an induction of COX‐2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post‐treatment. iNOS mRNA was also induced, but unlike COX‐2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX‐2 mRNA by 2‐hour IL‐1β treatment, and 2‐hour treatment with the PAF analog mcPAF mimicked the effects of IL‐1β on COX‐2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL‐1β‐PAF‐COX‐2 neuronal signaling. J. Neurosci. Res. 58:593–598, 1999. © 1999 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1097-4547(19991115)58:4<593::AID-JNR12>3.0.CO;2-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69215759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69215759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4722-4d689f7c6f0b2afe1c02e3784b1ccbfed3d7f8fc01cfa911075b2eb24e4b0b373</originalsourceid><addsrcrecordid>eNqFkd9u0zAUxiMEYqXwCshXaLtI8Z-4acoEmgqMbqOdYGjcHTnOyWaWOsFOoH1Y3gWXlIHEJK585PP5-47PL4peMTpilPLn-x_ns_kBo1kaJzJJ91mWZYwxeSAn0-RQZmI6PZq_jk8WHxh_KUZ0NFu-4HFyLxrcvrkfDagY0zihjO9Fj7z_QinNMikeRnuMSiGoZIPox9y26CrsboyNGcmxVUTp1nxTLXqC68ah96a2pC6J3uiqrtebK7TKY8yJsgUxtui0ySsk1rTOaFKvTYHEb2x7HVShTxpnVsptyLVpmlqrVaMqYrFztQ2F7qq2czgl51WIrLCNd_HGXpEy1LUjyhMVXLBEh7Y14dUKC6O2rbvG-jP14-hBqSqPT3bnMPr09s3F7F18tjyez47OYp2kPOytGE-yMtXjkuZclcg05SjSSZIzrfMSC1Gk5aTUlOlSBQ40lTnHnCeY5DQXqRhGz3rfxtVfO_QtrIzXWFXKYt15GGecyTRgG0aXvVC72vvwI9gtBxiFLXmALXnYUoQtRfhNHuQEEggWAIE8_CIPAijMlsAhCc5PdyN0edjOX7496iD43Au-mwo3_-T-N_au1P4iWMe9tfEtrm-tlbuBcSpSCZeLY3h_enpxvpAncCZ-AvYj4QY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69215759</pqid></control><display><type>article</type><title>Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Serou, Michael J. ; DeCoster, Mark A. ; Bazan, Nicolas G.</creator><creatorcontrib>Serou, Michael J. ; DeCoster, Mark A. ; Bazan, Nicolas G.</creatorcontrib><description>Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) genes by IL‐1β in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL‐1β (1 nM) led to an induction of COX‐2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post‐treatment. iNOS mRNA was also induced, but unlike COX‐2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX‐2 mRNA by 2‐hour IL‐1β treatment, and 2‐hour treatment with the PAF analog mcPAF mimicked the effects of IL‐1β on COX‐2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL‐1β‐PAF‐COX‐2 neuronal signaling. J. Neurosci. Res. 58:593–598, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/(SICI)1097-4547(19991115)58:4&lt;593::AID-JNR12&gt;3.0.CO;2-4</identifier><identifier>PMID: 10533051</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Animals ; Azepines - pharmacology ; BN50730 ; COX-2 ; Cyclooxygenase 2 ; Enzyme Induction - drug effects ; Enzyme Induction - physiology ; Hippocampus - cytology ; Hippocampus - drug effects ; Hippocampus - enzymology ; IL-1β ; Interleukin-1 - physiology ; Isoenzymes - biosynthesis ; Mice ; neurons ; Neurons - drug effects ; Neurons - enzymology ; Nitric Oxide Synthase - metabolism ; Nitric Oxide Synthase Type II ; PAF ; Platelet Activating Factor - analogs &amp; derivatives ; Platelet Activating Factor - pharmacology ; Platelet Aggregation Inhibitors - pharmacology ; Prostaglandin-Endoperoxide Synthases - biosynthesis ; Rats ; Recombinant Proteins - pharmacology ; seizures ; Thienopyridines ; Triazoles - pharmacology</subject><ispartof>Journal of neuroscience research, 1999-11, Vol.58 (4), p.593-598</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>Copyright 1999 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4722-4d689f7c6f0b2afe1c02e3784b1ccbfed3d7f8fc01cfa911075b2eb24e4b0b373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-4547%2819991115%2958%3A4%3C593%3A%3AAID-JNR12%3E3.0.CO%3B2-4$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-4547%2819991115%2958%3A4%3C593%3A%3AAID-JNR12%3E3.0.CO%3B2-4$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10533051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Serou, Michael J.</creatorcontrib><creatorcontrib>DeCoster, Mark A.</creatorcontrib><creatorcontrib>Bazan, Nicolas G.</creatorcontrib><title>Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) genes by IL‐1β in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL‐1β (1 nM) led to an induction of COX‐2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post‐treatment. iNOS mRNA was also induced, but unlike COX‐2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX‐2 mRNA by 2‐hour IL‐1β treatment, and 2‐hour treatment with the PAF analog mcPAF mimicked the effects of IL‐1β on COX‐2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL‐1β‐PAF‐COX‐2 neuronal signaling. J. Neurosci. Res. 58:593–598, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Azepines - pharmacology</subject><subject>BN50730</subject><subject>COX-2</subject><subject>Cyclooxygenase 2</subject><subject>Enzyme Induction - drug effects</subject><subject>Enzyme Induction - physiology</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - enzymology</subject><subject>IL-1β</subject><subject>Interleukin-1 - physiology</subject><subject>Isoenzymes - biosynthesis</subject><subject>Mice</subject><subject>neurons</subject><subject>Neurons - drug effects</subject><subject>Neurons - enzymology</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Nitric Oxide Synthase Type II</subject><subject>PAF</subject><subject>Platelet Activating Factor - analogs &amp; derivatives</subject><subject>Platelet Activating Factor - pharmacology</subject><subject>Platelet Aggregation Inhibitors - pharmacology</subject><subject>Prostaglandin-Endoperoxide Synthases - biosynthesis</subject><subject>Rats</subject><subject>Recombinant Proteins - pharmacology</subject><subject>seizures</subject><subject>Thienopyridines</subject><subject>Triazoles - pharmacology</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd9u0zAUxiMEYqXwCshXaLtI8Z-4acoEmgqMbqOdYGjcHTnOyWaWOsFOoH1Y3gWXlIHEJK585PP5-47PL4peMTpilPLn-x_ns_kBo1kaJzJJ91mWZYwxeSAn0-RQZmI6PZq_jk8WHxh_KUZ0NFu-4HFyLxrcvrkfDagY0zihjO9Fj7z_QinNMikeRnuMSiGoZIPox9y26CrsboyNGcmxVUTp1nxTLXqC68ah96a2pC6J3uiqrtebK7TKY8yJsgUxtui0ySsk1rTOaFKvTYHEb2x7HVShTxpnVsptyLVpmlqrVaMqYrFztQ2F7qq2czgl51WIrLCNd_HGXpEy1LUjyhMVXLBEh7Y14dUKC6O2rbvG-jP14-hBqSqPT3bnMPr09s3F7F18tjyez47OYp2kPOytGE-yMtXjkuZclcg05SjSSZIzrfMSC1Gk5aTUlOlSBQ40lTnHnCeY5DQXqRhGz3rfxtVfO_QtrIzXWFXKYt15GGecyTRgG0aXvVC72vvwI9gtBxiFLXmALXnYUoQtRfhNHuQEEggWAIE8_CIPAijMlsAhCc5PdyN0edjOX7496iD43Au-mwo3_-T-N_au1P4iWMe9tfEtrm-tlbuBcSpSCZeLY3h_enpxvpAncCZ-AvYj4QY</recordid><startdate>19991115</startdate><enddate>19991115</enddate><creator>Serou, Michael J.</creator><creator>DeCoster, Mark A.</creator><creator>Bazan, Nicolas G.</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991115</creationdate><title>Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression</title><author>Serou, Michael J. ; DeCoster, Mark A. ; Bazan, Nicolas G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4722-4d689f7c6f0b2afe1c02e3784b1ccbfed3d7f8fc01cfa911075b2eb24e4b0b373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Azepines - pharmacology</topic><topic>BN50730</topic><topic>COX-2</topic><topic>Cyclooxygenase 2</topic><topic>Enzyme Induction - drug effects</topic><topic>Enzyme Induction - physiology</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - enzymology</topic><topic>IL-1β</topic><topic>Interleukin-1 - physiology</topic><topic>Isoenzymes - biosynthesis</topic><topic>Mice</topic><topic>neurons</topic><topic>Neurons - drug effects</topic><topic>Neurons - enzymology</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Nitric Oxide Synthase Type II</topic><topic>PAF</topic><topic>Platelet Activating Factor - analogs &amp; derivatives</topic><topic>Platelet Activating Factor - pharmacology</topic><topic>Platelet Aggregation Inhibitors - pharmacology</topic><topic>Prostaglandin-Endoperoxide Synthases - biosynthesis</topic><topic>Rats</topic><topic>Recombinant Proteins - pharmacology</topic><topic>seizures</topic><topic>Thienopyridines</topic><topic>Triazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serou, Michael J.</creatorcontrib><creatorcontrib>DeCoster, Mark A.</creatorcontrib><creatorcontrib>Bazan, Nicolas G.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serou, Michael J.</au><au>DeCoster, Mark A.</au><au>Bazan, Nicolas G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>1999-11-15</date><risdate>1999</risdate><volume>58</volume><issue>4</issue><spage>593</spage><epage>598</epage><pages>593-598</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>Interleukin‐1 beta (IL‐1β) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL‐1β and its receptor can also be observed in normal brain. Platelet‐activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) genes by IL‐1β in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL‐1β (1 nM) led to an induction of COX‐2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post‐treatment. iNOS mRNA was also induced, but unlike COX‐2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX‐2 mRNA by 2‐hour IL‐1β treatment, and 2‐hour treatment with the PAF analog mcPAF mimicked the effects of IL‐1β on COX‐2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL‐1β‐PAF‐COX‐2 neuronal signaling. J. Neurosci. Res. 58:593–598, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10533051</pmid><doi>10.1002/(SICI)1097-4547(19991115)58:4&lt;593::AID-JNR12&gt;3.0.CO;2-4</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-4012
ispartof Journal of neuroscience research, 1999-11, Vol.58 (4), p.593-598
issn 0360-4012
1097-4547
language eng
recordid cdi_proquest_miscellaneous_69215759
source MEDLINE; Wiley Online Library Journals
subjects Animals
Azepines - pharmacology
BN50730
COX-2
Cyclooxygenase 2
Enzyme Induction - drug effects
Enzyme Induction - physiology
Hippocampus - cytology
Hippocampus - drug effects
Hippocampus - enzymology
IL-1β
Interleukin-1 - physiology
Isoenzymes - biosynthesis
Mice
neurons
Neurons - drug effects
Neurons - enzymology
Nitric Oxide Synthase - metabolism
Nitric Oxide Synthase Type II
PAF
Platelet Activating Factor - analogs & derivatives
Platelet Activating Factor - pharmacology
Platelet Aggregation Inhibitors - pharmacology
Prostaglandin-Endoperoxide Synthases - biosynthesis
Rats
Recombinant Proteins - pharmacology
seizures
Thienopyridines
Triazoles - pharmacology
title Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T17%3A49%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-1%20beta%20activates%20expression%20of%20cyclooxygenase-2%20and%20inducible%20nitric%20oxide%20synthase%20in%20primary%20hippocampal%20neuronal%20culture:%20Platelet-activating%20factor%20as%20a%20preferential%20mediator%20of%20cyclooxygenase-2%20expression&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Serou,%20Michael%20J.&rft.date=1999-11-15&rft.volume=58&rft.issue=4&rft.spage=593&rft.epage=598&rft.pages=593-598&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/(SICI)1097-4547(19991115)58:4%3C593::AID-JNR12%3E3.0.CO;2-4&rft_dat=%3Cproquest_cross%3E69215759%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69215759&rft_id=info:pmid/10533051&rfr_iscdi=true